| |
| |
|
| Insider
Information: |
Stilley William B. Iii |
| Relationship: |
Director |
| City: |
Charlottesville, |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
1,261,779 |
|
|
Indirect Shares
|
132,141 |
|
|
| Direct
Value |
$298,411 |
|
|
|
Indirect Value
|
$31,251 |
|
|
| Total
Shares |
1,393,920 |
|
|
| Total
Value |
$329,662 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 62.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adial Pharmaceuticals, Inc. |
ADIL |
Director |
2023-05-23 |
1,261,779 |
2018-07-31 |
132,141 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
10 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADIL |
Adial Pharmaceuticals, In... |
Director |
– • – |
2023-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
240,800 |
1,261,779 |
0 |
- |
|
| ADIL |
Adial Pharmaceuticals, In... |
Director |
– • – |
2022-12-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(166,667) |
1,020,979 |
0 |
- |
|
| ADIL |
Adial Pharmaceuticals, In... |
Chief Executive Officer |
• • – |
2022-02-23 |
4 |
A |
$0.00 |
$0 |
D/D |
250,000 |
1,187,646 |
0 |
- |
|
| ADIL |
Adial Pharmaceuticals, In... |
Chief Executive Officer |
• • • |
2021-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
201,109 |
917,046 |
0 |
- |
|
| ADIL |
Adial Pharmaceuticals, In... |
Chief Executive Officer |
• • • |
2020-03-26 |
4 |
B |
$1.47 |
$18,598 |
D/D |
12,652 |
715,937 |
3.15 |
% |
|
| ADIL |
Adial Pharmaceuticals, In... |
Chief Executive Officer |
• • • |
2020-03-25 |
4 |
B |
$1.13 |
$13,953 |
D/D |
12,348 |
703,285 |
3.15 |
% |
|
| ADIL |
Adial Pharmaceuticals, In... |
Chief Executive Officer |
• • • |
2020-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
54,167 |
690,937 |
0 |
- |
|
| ADIL |
Adial Pharmaceuticals, In... |
Chief Executive Officer |
• • • |
2018-07-31 |
4 |
B |
$0.00 |
$0 |
D/D |
80,000 |
504,000 |
3.15 |
- |
|
| ADIL |
Adial Pharmaceuticals, In... |
Chief Executive Officer |
• • • |
2018-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
52,227 |
424,629 |
0 |
- |
|
| ADIL |
Adial Pharmaceuticals, In... |
Chief Executive Officer |
• • • |
2018-07-31 |
4 |
A |
$0.00 |
$0 |
D/D |
36,800 |
372,402 |
0 |
- |
|
10 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
